These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16678956)
1. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study. Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956 [TBL] [Abstract][Full Text] [Related]
2. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related]
3. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404 [TBL] [Abstract][Full Text] [Related]
4. Defense style in panic disorder before and after pharmacological treatment. Marchesi C; Parenti P; Aprile S; Cabrino C; De Panfilis C Psychiatry Res; 2011 May; 187(3):382-6. PubMed ID: 20692044 [TBL] [Abstract][Full Text] [Related]
5. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260 [TBL] [Abstract][Full Text] [Related]
6. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study. Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891 [TBL] [Abstract][Full Text] [Related]
7. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study. Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643 [TBL] [Abstract][Full Text] [Related]
9. Psychiatric comorbidity in chronic disabling occupational spinal disorders has minimal impact on functional restoration socioeconomic outcomes. Dersh J; Mayer T; Gatchel RJ; Towns B; Theodore B; Polatin P Spine (Phila Pa 1976); 2007 Aug; 32(17):1917-25. PubMed ID: 17762302 [TBL] [Abstract][Full Text] [Related]
10. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961 [TBL] [Abstract][Full Text] [Related]
11. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders]. Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870 [TBL] [Abstract][Full Text] [Related]
12. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Lee JH; Dunner DL Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265 [TBL] [Abstract][Full Text] [Related]
13. Comorbid cannabis use and panic disorder: short term and long term follow-up study. Dannon PN; Lowengrub K; Amiaz R; Grunhaus L; Kotler M Hum Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 14994319 [TBL] [Abstract][Full Text] [Related]
14. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic. Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945 [TBL] [Abstract][Full Text] [Related]
15. Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder. Singareddy R; Uhde TW J Affect Disord; 2009 Jan; 112(1-3):262-6. PubMed ID: 18558437 [TBL] [Abstract][Full Text] [Related]
16. Patterns of axis II comorbidity in early-onset versus late-onset panic disorder in Japan. Iketani T; Kiriike N; Stein MB; Nagao K; Minamikawa N; Shidao A; Fukuhara H Compr Psychiatry; 2004; 45(2):114-20. PubMed ID: 14999662 [TBL] [Abstract][Full Text] [Related]
17. Recurrence of panic disorder during pregnancy: a 7-year naturalistic follow-up study. Dannon PN; Iancu I; Lowengrub K; Grunhaus L; Kotler M Clin Neuropharmacol; 2006; 29(3):132-7. PubMed ID: 16772811 [TBL] [Abstract][Full Text] [Related]
18. Pilot open-label study of nefazodone in panic disorder. Bystritsky A; Rosen R; Suri R; Vapnik T Depress Anxiety; 1999; 10(3):137-9. PubMed ID: 10604088 [TBL] [Abstract][Full Text] [Related]
19. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS; Ng F; Berk M Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778 [TBL] [Abstract][Full Text] [Related]
20. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study. Pecknold JC; Luthe L; Iny L; Ramdoyal D J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]